Elastomeric silicone containing an active ingredient
First Claim
1. A composition comprising an elastomeric silicone polyether prepared by a method comprising combining and reacting:
- (A) an ≡
Si—
H containing polysiloxane of the formula R3SiO(R′
2SiO)a(R″
HSiO)bSiR3, the formula (R′
2SiO)a′
(R″
HSiO)b′
, the formula HR2SiO(R′
2SiO)cSiR2H, or the formula HR2SiO(R′
2SiO)a(R″
HSiO)bSiR2H, where R, R′
, and R″
are alkyl groups with 1-6 carbon atoms, a is 0-250, a′
is 0-7, b is 1-250, b′
is 3-10, and c is 0-250;
(B) a mono-alkenyl polyether of the formula CH2═
CH(CH2)fO(CH2CH2O)g(CH2CH3CHO)hT, or the formula CH2═
CH—
Q—
O(CH2CH2O)g(CH2CH3CHO)hT, where T is hydrogen, a C1-C10 alkyl group, an aryl group, or a C1-C20 acyl group;
Q is a divalent linking group containing unsaturation;
f is 0-6, g is 4-100; and
h is zero or 1-100;
(C) an active ingredient capable of furnishing pharmacological activity or other direct effect in diagnosis, cure, mitigation, treatment, or prevention of disease, or which affects structures or functions of the body of man or other animal, including components that undergo chemical change in the manufacture of drug products or are present in drug products in a modified form intended to furnish specified activities or effects;
(D) an α
,ω
-unsaturated hydrocarbon selected from the group consisting of α
,ω
-dienes of the formula CH2═
CH(CH2)dCH═
CH2, α
,ω
-diynes of the formula CH≡
C(CH2)eC≡
CH, and α
,ω
-ene-ynes of the formula CH2═
CH(CH2)eC≡
CH, where d is 0-20 and e is 0-20; and
(E) a platinum catalyst;
in the presence of (F) an oil selected from the group consisting of (i) organic compounds, (ii) compounds containing a silicon atom, (iii) mixtures of organic compounds, (iv) mixtures of compounds containing a silicon atom, and (v) mixtures of organic compounds and compounds containing a silicon atom;
and allowing the reaction to continue until there is formed a crosslinked three-dimensional gelled network of an elastomeric silicone polyether containing the active ingredient and the oil.
1 Assignment
0 Petitions
Accused Products
Abstract
Elastomeric silicones, especially elastomeric silicone polyethers, are prepared by combining and reacting (A) an ≡Si—H containing polysiloxane, (B) a mono-alkenyl polyether, (C) an active ingredient such as a vitamin, antimicrobial agent, sunburn prevention agent, astringent, or sex hormone, (D) an α,ω-unsaturated hydrocarbon, (E) a platinum catalyst, and (F) an oil. The reaction of components (A)-(F) is allowed to continue, forming a crosslinked three-dimensional gelled network of the elastomeric silicone polyether containing the active ingredient and the oil. The compositions are useful in personal and health care applications, personal hygiene, and household cleaning applications.
-
Citations
11 Claims
-
1. A composition comprising an elastomeric silicone polyether prepared by a method comprising combining and reacting:
-
(A) an ≡
Si—
H containing polysiloxane of the formula R3SiO(R′
2SiO)a(R″
HSiO)bSiR3, the formula (R′
2SiO)a′
(R″
HSiO)b′
, the formula HR2SiO(R′
2SiO)cSiR2H, or the formula HR2SiO(R′
2SiO)a(R″
HSiO)bSiR2H, where R, R′
, and R″
are alkyl groups with 1-6 carbon atoms, a is 0-250, a′
is 0-7, b is 1-250, b′
is 3-10, and c is 0-250;
(B) a mono-alkenyl polyether of the formula CH2═
CH(CH2)fO(CH2CH2O)g(CH2CH3CHO)hT, or the formula CH2═
CH—
Q—
O(CH2CH2O)g(CH2CH3CHO)hT, where T is hydrogen, a C1-C10 alkyl group, an aryl group, or a C1-C20 acyl group;
Q is a divalent linking group containing unsaturation;
f is 0-6, g is 4-100; and
h is zero or 1-100;
(C) an active ingredient capable of furnishing pharmacological activity or other direct effect in diagnosis, cure, mitigation, treatment, or prevention of disease, or which affects structures or functions of the body of man or other animal, including components that undergo chemical change in the manufacture of drug products or are present in drug products in a modified form intended to furnish specified activities or effects;
(D) an α
,ω
-unsaturated hydrocarbon selected from the group consisting of α
,ω
-dienes of the formula CH2═
CH(CH2)dCH═
CH2, α
,ω
-diynes of the formula CH≡
C(CH2)eC≡
CH, and α
,ω
-ene-ynes of the formula CH2═
CH(CH2)eC≡
CH, where d is 0-20 and e is 0-20; and
(E) a platinum catalyst;
in the presence of(F) an oil selected from the group consisting of (i) organic compounds, (ii) compounds containing a silicon atom, (iii) mixtures of organic compounds, (iv) mixtures of compounds containing a silicon atom, and (v) mixtures of organic compounds and compounds containing a silicon atom;
and allowing the reaction to continue until there is formed a crosslinked three-dimensional gelled network of an elastomeric silicone polyether containing the active ingredient and the oil. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. A composition comprising an elastomeric silicone polyether prepared by a method comprising combining and reacting:
-
(A) an ≡
Si—
H containing polysiloxane of the formula R3SiO(R′
2SiO)a(R″
HSiO)bSiR3, the formula (R′
2SiO)a′
(R″
HSiO)b′
, the formula HR2SiO(R′
2SiO)cSiR2H, or the formula HR2SiO(R′
2SiO)a(R″
HSiO)bSiR2H, where R, R′
, and R″
are alkyl groups with 1-6 carbon atoms, a is 0-250, a′
is 0-7, b is 1-250, b′
is 3-10, and c is 0-250;
(B) a mono-alkenyl polyether of the formula CH2═
CH(CH2)fO(CH2CH2O)g(CH2CH3CHO)hT, or the formula CH2═
CH—
Q—
O(CH2CH2O)g(CH2CH3CHO)hT, where T is hydrogen, a C1-C10 alkyl group, an aryl group, or a C1-C20 acyl group;
Q is a divalent linking group containing unsaturation;
f is 0-6, g is 4-100; and
h is zero or 1-100;
(C) an active ingredient selected from the group consisting of vitamins, antimicrobial agents, sunburn prevention agents, astringents, and hormones;
(D) an α
,ω
-unsaturated hydrocarbon selected from the group consisting of α
,ω
-dienes of the formula CH2═
CH(CH2)dCH═
CH2, α
,ω
-diynes of the formula CH≡
C(CH2)eC≡
CH, and α
,ω
-ene-ynes of the formula CH2═
CH(CH2)eC≡
, where d is 0-20 and e is 0-20; and
(E) a platinum catalyst;
in the presence of(F) an oil selected from the group consisting of (i) organic compounds, (ii) compounds containing a silicon atom, (iii) mixtures of compounds, (iv) mixtures of compounds containing a silicon atom, and (v) mixtures of organic compounds and atom;
compounds containing a silicon atom;
and allowing the reaction to continue until there is formed a crosslinked three-dimensional gelled network of an elastomeric silicone polyether containing the active ingredient and the oil.
-
-
11. A composition comprising an elastomeric silicone prepared by a method comprising combining and reacting:
-
(A) an ≡
Si—
H containing polysiloxane of the formula R3SiO(R′
2SiO)a(R″
HSiO)bSiR3, the formula (R′
2SiO)a′
(R″
HSiO)b′
, the formula HR2SiO(R′
2SiO)cSiR2H, or the formula HR2SiO(R′
2SiO)a(R″
HSiO)bSiR2H, where R, R′
, and R″
are alkyl groups with 1-6 carbon atoms, a is 0-250, a′
is 0-7, b is 1-250, b′
is 3-10, and c is 0-250;
(B) optionally, a mono-alkenyl polyether, an α
-olefin, or a mono-alkenyl polyether and an α
-olefin;
(C) an active ingredient selected from the group consisting of vitamins, antimicrobial agents, sunburn prevention agents, astringents, and hormones;
(D) an α
,ω
-unsaturated hydrocarbon selected from the group consisting of α
,ω
-dienes of the formula CH2═
CH(CH2)dCH═
CH2, α
,ω
-diynes of the formula CH≡
C(CH2)eC≡
CH, and α
,ω
-ene-ynes of the formula CH2═
CD(CH2)eC≡
CH, where d is 0-20 and e is 0-20; and
(E) a platinum catalyst;
in the presence of (F) an oil selected from the group consisting of (i) organic compounds, (ii) compounds containing a silicon atom, (iii) mixtures of organic compounds, (iv) mixtures of compounds containing a silicon atom, and (v) mixtures of organic compounds and compounds containing a silicon atom;
and allowing the reaction to continue until there is formed a crosslinked three-dimensional gelled network of an elastomeric silicone containing the active ingredient and the oil.
-
Specification